The iStopMM (Iceland Screens, Treats or Prevents Multiple Myeloma) study, which involved Icelanders over the age of 40, discovered a high prevalence of smoldering MM (SMM) by screening the general population for M‐protein.10, 11. This evidence concerns the gene MYOM2 and plasma cell myeloma.